Tsai, Shan-Ko
Hsu, Yu-Lin
Chiao, Der-Jiang
Shu, Pei-Yun
Lin, Hui-Tsu
Chang, Shu-Fen
Lin, Hui-Chung
Huang, Shih-Hsin
Wang, Chun-Hsiung
Hsiung, Chia-Chu
Lin, Chang-Chi
Wu, Tzong-Yuan
Kuo, Szu-Cheng http://orcid.org/0000-0001-6803-0685
Funding for this research was provided by:
National Health Research Institutes (NHRI-110A1-MRCO-08212101, NHRI-11A1-MRCO-08222201)
Ministry of Science and Technology (MOST 109-2327-B-016-002, MOST 110-2740-B-016-001)
Medical Affairs Bureau (MND-MAB-110-075, MND-MAB-D-111081, IPM-110-G7, 111-P-12)
Article History
Received: 28 July 2022
Revised: 11 October 2022
Accepted: 4 November 2022
First Online: 25 November 2022
Declarations
:
: The Institutional Animal Care approved the animal study protocol and Use Committee (Institute of Preventive Medicine, National Defense Medical Center, Taiwan) is to ensure compliance with 3Rs (Replacement, Reduction and Refinement) spirit. (Project License: 109–20 in 2021). This study involving clinical human serum samples reviewed and approved by the Taiwan Centers for Disease Control Institutional Review Board (IRB 109105).
: The authors declare no competing interests.
Free to read: This content has been made available to all.